Research Focus
Non-genomic effects of aldosterone: new actions and questions

https://doi.org/10.1016/j.tem.2004.08.002Get rights and content

Although the classical actions of aldosterone are mediated through genomic pathways, there is a growing recognition of important nongenomic responses to aldosterone. New data are presented from two laboratories showing a nongenomic effect of aldosterone to activate protein kinase C (PKC) in heart and kidney. Among the actions of PKC is the stimulation of transcription factors, raising the question of whether there is an inter-relationship of nongenomic with genomic influences – aldosterone induced nongenomic effects might modulate genomic effects. This expanded role of aldosterone will require exploration in future studies.

Section snippets

Non-genomic influences genomic?

A question arises from consideration of the intermediary role of PKCε – to what extent are genomic actions of aldosterone dependent on its non-genomic actions? An increase in PKC activity results in activation of transcription factors, and thus non-genomic influences obviously give rise to at least some genomic regulation (Figure 1). Could the non-genomic action of aldosterone lead to a modulation of aldosterone's genomic action, functioning either to enhance or mitigate the genomic response?

Conclusion

Non-genomic influences of aldosterone are becoming more widely recognized. This is in part a result of the growing awareness of the effects of aldosterone on non-epithelial sites (e.g. heart and kidney) in which non-genomic actions could partner with genomic actions. The non-genomic story has seemingly been stifled by the elusive nature of the membrane receptor. However it would seem that there is much to learn without knowing the nature of ‘the receptor’ as demonstrated by the papers of

Acknowledgements

Support provided by NIH grants R01-HL-35795 and RO1-HL-67360 and by the Department of Veterans Affairs.

References (6)

  • R. Schulz

    Induction and potential biological relevance of a Ca(2+)-independent nitric oxide synthase in the myocardium

    Br. J. Pharmacol.

    (1992)
  • C. Winter

    Nongenomic stimulation of vacuolar H+-ATPases in intercalated renal tubule cells by aldosterone

    Proc. Natl. Acad. Sci. U. S. A.

    (2004)
  • A.S. Mihailidou

    Rapid, nongenomic effects of aldosterone in the heart mediated by epsilon protein kinase C

    Endocrinology

    (2004)
There are more references available in the full text version of this article.

Cited by (24)

  • Mineralocorticoid Action in the Aldosterone-Sensitive Distal Nephron

    2007, Seldin and Giebisch's The Kidney: Physiology & Pathophysiology 1-2
  • Regulation of epithelial Na<sup>+</sup> channels (ENaC) by methylation: A novel methyltransferase stimulates ENaC activity

    2006, Journal of Biological Chemistry
    Citation Excerpt :

    In this classic genomic model, the early effects of aldosterone to stimulate ENaC activity may be due to trafficking of already synthesized channel subunits, under the influence of the aldosterone-induced protein SGK-1 (27, 29), or to a direct effect on channel open probability (3). Early and rapid non-genomic effects of aldosterone have also been described in a number of tissues and cell types that are not related to binding of the classic mineralocorticoid receptor, and among these effects are direct, rapid (<2 min) activation of ENaC (5–8). In the CCD cells that we have used in these studies, all the effects of aldosterone appear to be mediated via the classic, genomic pathway (17), although it seems clear that the early phase of stimulation of ENaC activity is not fully explained by activation of SGK-1, suggesting that other pathways may be involved (8, 29, 30).

  • The renin angiotensin aldosterone system

    2024, Pflugers Archiv European Journal of Physiology
View all citing articles on Scopus
View full text